H.u.group Holdings, Inc. (4544) Press Release
【Summary】Consolidated Financial Results for the Three Months Ended June 30, 2026 (Under Japanese GAAP)
Earlier from H.u.group
- Notice Concerning the Status of the Acquisition of Treasury Stock
- Fujirebio and Sysmex Begin Sales Collaboration for Dementia Testing
- H.U. Group Holdings Inc. - Fujirebio further extends its fully automated blood-based biomarker portfolio with the fully automated Lumipulse G ApoE4 and Lumipulse G Pan-ApoE assays for Research Use Only
- H U: Fujirebio acquires ADx NeuroSciences